Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA known ✓ | P06280 | 1/20 | 0.30 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.30 |
| ▸ | HTR2A known ✓ | P28223 | 3/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6398056 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL6879846 | 0.70 | CYP2D6 (0.32) | ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL1005442 | 0.64 | KDM4E (0.30) | KDM4ENPC1ALDH1A1TP53GLA | |
| SCHEMBL4607064 | 0.61 | SLC18A3 (0.36) | KDM4EALDH1A1GAASMN1; SMN2 | |
| SCHEMBL9444404 | 0.57 | BRD4 (0.47) | KDM4ENPC1ALDH1A1RAB9A | |
| SCHEMBL315078 | 0.55 | HTR2A (0.41) | ALDH1A1L3MBTL1HTR2A | |
| SCHEMBL4266302 | 0.55 | ALDH1A1 (0.41) | NPC1ALDH1A1RAB9ASMN1; SMN2L3MBTL1 | |
| SCHEMBL840559 | 0.55 | PTGS2 (0.34) | — | |
| SCHEMBL27633315 | 0.54 | HTR2A (0.40) | KDM4ENPC1ALDH1A1TP53HPGD | |
| Styrene SCHEMBL27201704 | 0.54 | ALDH1A1 (0.78) | ALDH1A1TP53L3MBTL1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215136-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT | ZEON CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250215137-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | ZEON CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250091969-A1 | CYCLOPENTENE RECOVERY METHOD | ZEON CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4502014-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4502059-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4461720-A1 | CYCLOPENTENE RECOVERY METHOD | Zeon Corporation (JP) | 2024-11-13 | — | — | EP | disclosed |
| WO-2023189496-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023189497-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11707648-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
| WO-2023132366-A1 | CYCLOPENTENE RECOVERY METHOD | 日本ゼオン株式会社 | 2023-07-13 | — | — | WO | disclosed |
| EP-1655343-A1 | CROSSLINKABLE RESIN COMPOSITION AND RESIN FORMED BODY PRODUCED THEREFROM | Zeon Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1655319-A1 | POLYMERIZABLE COMPOSITION AND FORMED BODY THEREOF | Zeon Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1655321-A1 | POLYMERIZABLE COMPOSITIONS AND MOLDED ARTICLES PRODUCED BY USING THE SAME | Zeon Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1652885-A1 | POLYMERIZABLE COMPOSITION AND FORMED ARTICLE USING THE SAME | Zeon Corporation (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-7037993-B2 | Norbornene-based ring-opening polymerization polymer, product of hydrogenation of norbornene-based ring-opening polymerization polymer, and processes for producing these | ZEON CORPORATION (JP) | 2006-05-02 | — | — | US | disclosed |
| EP-1640153-A1 | MULTILAYER BODY AND METHOD FOR PRODUCING SAME | Zeon Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
| EP-1589055-A1 | PROCESS FOR PRODUCING CYCLOOLEFIN RESIN FILM AND PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER SHEET OR FILM | Zeon Corporation (JP) | 2005-10-26 | — | — | EP | disclosed |
| EP-1589054-A1 | POLYMERIZABLE COMPOSITION, THERMOPLASTIC RESIN COMPOSITION, CROSSLINKED RESIN, AND CROSSLINKED RESIN COMPOSITE MATERIALS | Zeon Corporation (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20050148746-A1 | Norbornene-based ring-opening polymerization polymer, product of hydrogenation of norbornene-based ring-opening polymerization polymer, and processes for producing these | ZEON CORPORATION (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-1535941-A1 | PROCESSES FOR PRODUCING THERMOPLASTIC RESINS, CROSSLINKED RESINS AND CROSSLINKED RESIN COMPOSITE MATERIALS | ZEON CORPORATION (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091969-A1 | CYCLOPENTENE RECOVERY METHOD | CYC1, CYCS, DHPS | GLA 2649/4885GAA 4437/4885HTR2A 2470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.